Coriell's President and CEO, Dr. Michael Christman, was recognized as one of the region's top executives of the year by Southern New Jersey Business People Magazine.
read moreOver the course of five days at the end of April, upwards of 9,000 technology leaders and business entrepreneurs gathered for the 2014 IBM Impact Conference in Las Vegas, NV.
read moreA team from Coriell showcased the exciting initiatives taking place at the Institute during the 2014 International Society for Stem Cell Research Annual Meeting held in Vancouver, Canada late last month.
read moreDr. Steven Madore, Coriell's Director of Biobanking, is identified by South Jersey Biz magazine as one of the region's most influential figures in the healthcare field.
read moreIn an exploratory article on of the explosive growth of personalized medicine and the important role technology plays in this paradigm shift, Coriell Institute's president and CEO, Dr. Michael Christman discusses the work being done by the Coriell Personalized Medicine Collaborative research study.
read moreThis March, Coriell's Director of Government Affairs and Policy, Susan Delaney, was honored alongside fellow New Jersey women leaders in the State Assembly chambers for leadership in the life sciences.
read moreHundreds of students, teachers, family and friends turned up at the Camden County College campus in late March to support the region's stellar science education programs.
read moreCoriell Institute was identified as a community leader contributing to the revival of industry in Camden in an article written by Philadelphia's NBC10 and NewsWorks, an extension of WHYY.
read moreDr. Michael Christman, Coriell's President and CEO and a founding member of Coriell Life Sciences (CLS), and Scott Megill, President and CEO of CLS, spoke with Aaron Krol of Bio-IT World for an update on personalized medicine efforts at Coriell.
read moreCoriell Institute was recently awarded a milestone contract extension for its National Institute for Neurological Disorders and Stroke (NINDS) repository, which houses an extensive and diverse collection of biospecimens assembled to facilitate studies aimed at accelerating the discovery of disease-relevant biomarkers for neurological disorders and neurodegenerative diseases such as Parkinson's Disease and Huntington's Disease.
read more